Seema Dawood: Acquired Platelet Dysfunction with Eosinophilia – Bleeding Despite Normal Platelet Count
Seema Dawood, Medical Laboratory Technologist at The Aga Khan University Hospital, shared a post on LinkedIn:
“Acquired Platelet Dysfunction with Eosinophilia (APDE)
Condition characterized by bleeding tendency due to abnormal Platelet function, despite having a normal or near-normal platelet count, occurring together with Eosinophilia (increased Eosinophils in the blood).
Key Features
Patients present with abnormal bleeding: purpura, epistaxis, gum bleeding, etc.
Platelet count is usually normal, but platelet function is impaired.
Eosinophilia is present, commonly associated with:
- Parasitic infections
- Allergic diseases
- Certain immune-mediated conditions
Pathophysiology
Eosinophils release toxic granule proteins (e.g., Major Basic Protein, Eosinophil Cationic Protein).
These substances interfere with platelet function (aggregation and adhesion).
Result: ineffective hemostasis despite normal platelet count.
Clinical Importance
- Patients may have bleeding tendency even though platelet count is normal.
- Reported frequently in regions with high prevalence of parasitic infections (e.g., Southeast Asia).
- Treatment focuses on managing the underlying cause of Eosinophilia (e.g., treating parasitic infections).
- Once eosinophil count decreases, platelet function usually improves.
Summary:
APDE is an acquired condition where platelet dysfunction occurs in association with Eosinophilia, leading to bleeding tendency despite normal platelet count.
It is often linked to parasitic infections or allergies and improves when Eosinophilia is treated.
APDE is the only disease in which Pale Platelets are found.
Therefore, before reporting Pale Platelets, it is important to consider other consistent findings such as marked eosinophilia and the presence of purpura in the patient.”

See more in the gallery.
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?